Publications

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.

LAWN, SD; Meintjes, G; McIlleron, H; Harries, AD; Wood, R;

2013

BMC medicine, (2013).11 1 10.1186/1741-7015-11-253.

Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB.

Jackson-Sillah, D; CLIFF, JM; Mensah, GI; Dickson, E; Sowah, S; Tetteh, JK A; Addo, KK; Ottenhoff, TH M; Bothamley, G; DOCKRELL, HM;

2013

PloS one, (2013).8 6 10.1371/journal.pone.0068121.

Assessing the effects of HIV/AIDS and TB disease control programmes on health systems in low- and middle-income countries of Southeast Asia: a semi-systematic review of the literature.

CONSEIL, A; MOUNIER-JACK, S; RUDGE, JW; COKER, R;

2013

Public health, (2013).127 12 10.1016/j.puhe.2013.09.013.

Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance.

Sheen, P; Couvin, D; Grandjean, L; Zimic, M; Dominguez, M; Luna, G; Gilman, RH; Rastogi, N; MOORE, DA J;

2013

PloS one, (2013).8 6 10.1371/journal.pone.0065873.

Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Hur, Y-G; CRAMPIN, AC; Chisambo, C; Kanyika, J; HOUBEN, R; Ndhlovu, R; MZEMBE, T; Lalor, MK; SAUL, J; BRANSON, K; Stanley, C; Ngwira, B; FRENCH, N; Ottenhoff, TH; DOCKRELL, HM; GORAK-STOLINSKA, P;

2013

Clinical and vaccine immunology, (2013).21 2 10.1128/CVI.00620-13.

Drug-resistant tuberculosis: time for visionary political leadership.

Abubakar, I; Zignol, M; Falzon, D; Raviglione, M; Ditiu, L; Masham, S; ADETIFA, I; Ford, N; Cox, H; LAWN, SD; Marais, BJ; McHugh, TD; Mwaba, P; Bates, M; Lipman, M; Zijenah, L; Logan, S; MCNERNEY, R; Zumla, A; Sarda, K; Nahid, P; Hoelscher, M; Pletschette, M; Memish, ZA; Kim, P; ... Zumla, A.

2013

The Lancet infectious diseases, (2013).13 6 10.1016/S1473-3099(13)70030-6.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel, J; Roper, MH; Herrera, C; Bonilla, C; Jave, O; Gianella, C; Sabogal, I; Huancaré, V; Leo, E; Tyas, A; Mendoza-Ticona, A; Caviedes, L; MOORE, DA J;

2013

Clinical microbiology and infection, (2013).20 6 10.1111/1469-0691.12401.

Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

MacPherson, P; HOUBEN, RM G J; GLYNN, JR; CORBETT, EL; KRANZER, K;

2013

Bulletin of the World Health Organization, (2013).92 2 10.2471/BLT.13.124800.

Multidrug-resistant tuberculosis in UK children: presentation, management and outcome.

Williams, B; Ramroop, S; Shah, P; Anderson, L; Das, S; Riddell, A; Liebeschuetz, S; BASU ROY, R; O'Callaghan, M; Sloper, K; Bernatoniene, J; Shingadia, D; KAMPMANN, B;

2013

The European respiratory journal, (2013).41 6 10.1183/09031936.00179712.

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

Hur, Y-G; GORAK-STOLINSKA, P; Ben-Smith, A; Lalor, MK; Chaguluka, S; Dacombe, R; Doherty, TM; Ottenhoff, TH; DOCKRELL, HM; CRAMPIN, AC;

2013

PloS one, (2013).8 11 10.1371/journal.pone.0079742.